요실금 디바이스 시장 규모, 점유율, 동향, 예측 : 제품별, 카테고리별, 요실금 유형, 환자, 최종사용자, 지역별(2025-2033년)

The global urinary incontinence devices market size was valued at USD 3.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 7.2 Billion by 2033, exhibiting a CAGR of 8.88% during 2025-2033. North America currently dominates the market in 2024. The growing occurrence of neurological diseases, diabetes, and obesity, the increasing number of individuals who are addicted to smoking and alcohol consumption, and the rising preference of patients to opt for minimally invasive (MI) treatment options represent some of the key factors driving the market across the region.

The global urinary incontinence devices market is primarily driven by an increasing geriatric population, which leads to a higher prevalence of incontinence among elderly individuals. Moreover, advancements in medical technology have led to the development of more comfortable, discreet, and effective urinary incontinence devices, further driving demand. Rising healthcare expenditure and a shift toward home healthcare services are also contributing to market growth, as patients increasingly prefer using these devices in the comfort of their homes. According to the IMARC Group, the home healthcare market size reached USD 424.0 Billion in 2024 and is forecasted to reach USD 816.4 Billion by 2033, exhibiting a CAGR of 7.48% during 2025-2033. Furthermore, the growing number of women experiencing incontinence issues is also expanding the market.

The United States has emerged as a key regional market for urinary incontinence devices, driven by the increasing geriatric population, as the incidence of incontinence increases with age, particularly among seniors. As per the National Council on Aging (NCOA), by 2040, adults over the age of 65 are projected to constitute 22% of the total population in the United States. In addition, increased awareness and education surrounding incontinence treatments have encouraged more individuals to seek devices to manage the condition. Technological advancements in urinary incontinence devices, which offer improved comfort, convenience, and discretion, are also fueling market growth. Moreover, the rising adoption of home healthcare services, combined with a preference for at-home management, has boosted demand for such devices.

Urinary Incontinence Devices Market Trends:

Increasing geriatric population globally

The urinary incontinence devices market growth is considerably influenced by the increasing geriatric population. According to industry reports, the total number of people aged 60 years and above is estimated to reach 2.1 Billion by 2050, making up 26% of the total global population. As lifespans continue to be longer, older populations are multiplying and with older age, patients increasingly suffer from urinary incontinence. It occurs when the patients develop weakened muscles in the pelvis. For instance, hypertrophied prostrate in males and alteration of hormonal conditions in females approaching the menopausal stage of life. The main reason these incontinence devices are in great demand is due to the fact that the demographic is highly prone to urinary disorders, creating a huge demand for effective management solutions. Incontinence devices such as absorbent pads, catheters, and external urinary devices play an essential role in helping the elderly manage their condition, hence propelling the market growth.

Significant technological advancements

Technological advancements in urinary incontinence product design and functionality are significantly driving the urinary incontinence devices market. What were originally large, cumbersome pieces have evolved to be highly effective, comfortable, and discreetly hidden. State-of-the-art technologies, for instance, now involve smart products for incontinence and wearables, leading to better absorption capabilities, improved fitting, and increased comfortability, which are all matters patients had reservations about with former products. Advanced materials such as breathable fabrics and moisture-wicking components further increase the attraction of these devices. Improvements in technology to make the device more functional, have better odor control, skin protection, and easy usage of the device make them more attractive for users, hence creating a demand globally.

Rising awareness and changing attitudes

Improving knowledge and evolving societal perceptions related to urinary incontinence have greatly contributed to its market development. In the past, urinary incontinence was considered a taboo subject and hidden by most. Consequently, such diagnosis and subsequent treatments were highly delayed. Mass campaigns for healthy lifestyles and health-related advocacy for increased awareness, particularly in regard to this matter, have eased much of that embarrassment about this condition. As a result, more people have been seeking some form of remedy, such as devices for urinary incontinence, rather than keeping silent about the condition. Furthermore, healthcare workers are now much more proactive in seeking to educate patients on the proper management of this condition, leading to increased knowledge of available devices. With growing awareness that this is a manageable condition, increased demand for devices continues to drive growth in the market.

Urinary Incontinence Devices Industry Segmentation:

Analysis by Product:

• Urinary Catheters
• Vaginal Slings
• Electrical Stimulation Devices
• Artificial Urinary Sphincters
• Others

Vaginal slings stand as the largest component in 2024. The primary reason for vaginal slings to dominate the urinary incontinence devices market is their effectiveness in treating stress urinary incontinence, particularly among women. The support provided by these devices helps the urethra and thereby prevents urine leakage during coughing or sneezing, among other physical activities. The device is minimally invasive and allows for relatively short recovery times with improved comfort as compared to other treatments. Vaginal slings are increasingly preferred because they provide a permanent solution, reducing the need for ongoing maintenance or repeated interventions. This combination of effectiveness, convenience, and durability continues to drive their dominance in the market.

Analysis by Category:

• External Urinary Incontinence Devices
• Internal Urinary Incontinence Devices

Internal urinary incontinence devices lead the market in 2024. The discreet, effective, and long-term management of urinary incontinence has led to internal urinary incontinence devices being the most dominating in the urinary incontinence devices market. Other devices in this category include urethral inserts, artificial urinary sphincters, and catheters, which provide an effective option to address stress as well as urge incontinence. All these devices promise better comfort and ease of living to patients. Patients find the devices appropriate because they are easy to use and adaptable to everyday activities. Internal devices are suitable for patients with more severe incontinence conditions and serve as a non-invasive but highly effective alternative to surgery. Their growth in adoption across health settings contributes to their market dominance.

Analysis by Incontinence Type:

• Stress Urinary Incontinence
• Urge Urinary Incontinence
• Overflow Urinary Incontinence
• Mixed Incontinence

Stress urinary incontinence represents the largest market share in 2024. Stress urinary incontinence, with a higher prevalence among females, dominates the market of urinary incontinence devices. Such an event mainly occurs due to pregnancy, childbearing, obesity, and old age, as all of these reduce the pelvic floor muscles' strength and, eventually, cause the loss of voluntary urine flow control by patients during sneezing, coughing, or doing exercises. As a result, there is a huge demand for effective and non-invasive devices to manage stress urinary incontinence, such as vaginal slings, pelvic floor stimulators, and urethral inserts. Long-term relief from these devices makes them the first choice in managing stress urinary incontinence, which propels their market dominance.

Analysis by Patient:

• Female
• Male

Female accounted for the leading market segment in 2024. Females form the majority share of the urinary incontinence devices market because, in comparison with men, there is a more significant prevalence of urinary incontinence among females, particularly stress urinary incontinence and urge incontinence. Pregnancy, childbirth, and menopause weaken pelvic floor muscles and make women more vulnerable to these conditions. The aging population and physiological differences in women's anatomy also increase the demand for urinary incontinence devices that are specifically designed. Thus, women are the largest demographic for incontinence treatment solutions, including devices such as vaginal slings, pelvic floor stimulators, and bladder control products, which is fueling the growth of the market.

Analysis by End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Hospitals exhibited a clear dominance in the market in 2024. Hospitals lead the market for urinary incontinence devices since they are key institutions in the diagnosis and treatment of patients with urinary incontinence, particularly in severe or complicated cases. Their care is special, including surgeries and access to more advanced devices for incontinence, such as artificial urinary sphincters, urethral slings, and catheters. In addition, hospitals have infrastructures that facilitate full care for patients and ensure long-term follow-up. The presence of trained healthcare professionals and a wide range of treatment options available make hospitals the primary setting for using urinary incontinence devices, hence driving their market share.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2024, North America accounted for the largest urinary incontinence devices market share, due to various crucial factors. The area exhibits a significant occurrence of urinary incontinence, especially among the elderly, creating a need for innovative solutions. Additionally, the area features a robust healthcare infrastructure that promotes the integration of advanced medical technologies. Supportive reimbursement policies additionally motivate patients and healthcare providers to use these devices. Furthermore, North America hosts leading manufacturers and suppliers of urinary incontinence products, enhancing product accessibility and innovation. The significant focus on research and development results in the launch of technologically sophisticated products, including minimally invasive instruments and wearable technologies, improving patient comfort and satisfaction.

Key Regional Takeaways:

United States Urinary Incontinence Devices Market Analysis

The rising adoption of urinary incontinence devices is closely tied to advancements in the healthcare sector. For instance, U.S. healthcare companies are securing venture capital deals of USD 15 Million and are driving robust investment growth, focusing on innovation in medical technology to meet rising market demands. Enhanced technological integration in diagnostics and treatment methodologies has elevated the efficiency and reliability of these devices. Healthcare providers are increasingly focusing on patient-centric care, incorporating minimally invasive solutions that offer comfort and long-term benefits. The availability of training programs for medical practitioners on device usage has further driven the preference for these advanced solutions. Additionally, the expansion of clinical trials has enabled innovation in material design and improved usability, making these devices more appealing. Access to state-of-the-art medical equipment and growing awareness about addressing urinary incontinence effectively have bolstered demand. Consumer confidence in modern treatment options and continuous product innovations designed for comfort and discretion play a vital role. Overall, increasing acceptance of innovative healthcare interventions continues to propel the market.

Asia Pacific Urinary Incontinence Devices Market Analysis

The prevalence of diabetes significantly influences the adoption of urinary incontinence devices in Asia Pacific, as the condition often leads to complications that require such interventions. According to the National Library of Medicine, the prevalence of diabetes in India has risen from 7.1% in 2009 to 8.9% in 2019. Rising healthcare literacy has encouraged early diagnosis and treatment, creating a growing demand for efficient solutions. The introduction of educational campaigns and improved access to medical infrastructure have empowered individuals to address their conditions proactively. Furthermore, advancements in manufacturing have reduced production costs, enabling a broader population to afford high-quality products. Collaborative efforts within the healthcare industry to offer tailored solutions have also strengthened the adoption rates. Increased participation in wellness programs focusing on diabetes management indirectly drives demand for complementary treatments, including incontinence care. Additionally, the integration of specialized features catering to the unique needs of patients with diabetes has made these devices more desirable. This upward trend reflects an evolving focus on holistic health management strategies.

Europe Urinary Incontinence Devices Market Analysis

Aging populations across the region have driven a marked increase in the adoption of urinary incontinence devices, as age-related health issues often necessitate their use. For instance, Europe's geriatric population is rising, with one in five Europeans now aged 65 or older, projected to approach 30% by 2050. Medical professionals are increasingly recommending urinary incontinence devices due to their effectiveness in managing age-associated conditions. Innovations in design have made them more comfortable and discreet, appealing to the elderly population. Community awareness initiatives emphasizing quality-of-life improvements have helped reduce the stigma around using such devices. Furthermore, the healthcare sector has prioritized solutions that ensure mobility and independence, aligning with the needs of older adults. Integration of user-friendly features, such as easy application and maintenance, has contributed to their growing popularity. The establishment of specialized healthcare facilities and home care services for senior citizens further supports this trend. As a result, the market is witnessing steady growth, catering to the unique requirements of the aging demographic.

Latin America Urinary Incontinence Devices Market Analysis

The rising incidence of obesity is a major factor driving the adoption of urinary incontinence devices in the region. According to a UN report, over the past 50 years, overweight and obesity rates have tripled, now impacting 62.5% of the region's population. Obesity is associated with an increased risk of urinary incontinence, prompting higher demand for effective management solutions. Advancements in healthcare have enabled better diagnosis and treatment, encouraging individuals to seek appropriate care. The availability of cost-effective and adaptable devices has also boosted their appeal. Awareness campaigns highlighting the link between obesity and urinary incontinence have played a significant role in reducing stigma and fostering demand for these devices. Additionally, improved access to healthcare professionals specializing in weight-related conditions has contributed to the growing adoption of incontinence management solutions.

Middle East and Africa Urinary Incontinence Devices Market Analysis

The expansion of healthcare infrastructure has significantly enhanced the adoption of urinary incontinence devices. According to the Dubai Healthcare City Authority report, Dubai's healthcare sector saw rapid growth, with 4,482 private medical facilities and 55,208 licensed professionals by 2022, projected to expand further by 3-6% in facilities and 10-15% in professionals in 2023. Improved accessibility to medical services has enabled more individuals to seek treatment for incontinence issues. Efforts to raise awareness about effective management options have encouraged greater acceptance of these devices. Enhanced focus on offering patient-centric care has driven innovation in device design, making them more user-friendly and comfortable. Increasing availability of specialized training for medical practitioners has also boosted their recommendations. As a result, the market continues to grow, reflecting the region's commitment to improving healthcare outcomes.

Competitive Landscape:

Key players in the urinary incontinence devices market are undertaking several strategic measures to drive the growth of the market. Leaders are focusing on product innovation and introducing advanced, more comfortable incontinence solutions with features such as better absorbency, breathability, and odor control. Additionally, they are investing in research and development (R&D) to incorporate smart technologies, such as wearable devices with sensors for real-time monitoring. These are further helped through strategic partnerships with healthcare providers and an expanding network of distribution. Besides this, the focus of companies on education and awareness regarding the benefits of these devices through focused marketing campaigns and awareness programs also increases product adoption in international markets.

The report provides a comprehensive analysis of the competitive landscape in the urinary incontinence devices market with detailed profiles of all major companies, including:

• B. Braun Melsungen AG
• Baxter International Inc
• Becton Dickinson and Company
• Boston Scientific Corporation
• Caldera Medical Inc.
• Coloplast A/S
• ConvaTec Group plc
• Cook Group Inc.
• Johnson & Johnson
• Kimberly-Clark Corporation
• Laborie Medical Technologies Inc.
• Medtronic plc
• Teleflex Incorporated

Key Questions Answered in This Report

• 1.What are urinary incontinence devices?
• 2.How big is the global urinary incontinence devices market?
• 3.What is the expected growth rate of the global urinary incontinence devices market during 2025-2033?
• 4.What are the key factors driving the global urinary incontinence devices market?
• 5.What is the leading segment of the global urinary incontinence devices market based on the product?
• 6.What is the leading segment of the global urinary incontinence devices market based on the category?
• 7.What is the leading segment of the global urinary incontinence devices market based on the incontinence type?
• 8.What is the leading segment of the global urinary incontinence devices market based on the patient?
• 9.What is the leading segment of the global urinary incontinence devices market based on the end user?
• 10.What are the key regions in the global urinary incontinence devices market?
• 11.Who are the key players/companies in the global urinary incontinence devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Urinary Incontinence Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Urinary Catheters
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Vaginal Slings
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Electrical Stimulation Devices
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Artificial Urinary Sphincters
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Category

• 7.1 External Urinary Incontinence Devices
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Internal Urinary Incontinence Devices
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Incontinence Type

• 8.1 Stress Urinary Incontinence
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Urge Urinary Incontinence
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Overflow Urinary Incontinence
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Mixed Incontinence
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Patient

• 9.1 Female
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Male
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by End User

• 10.1 Hospitals
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Ambulatory Surgical Centers
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Others
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia-Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 B. Braun Melsungen AG
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
    • 16.3.1.3 SWOT Analysis
  • 16.3.2 Baxter International Inc
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
    • 16.3.2.3 Financials
    • 16.3.2.4 SWOT Analysis
  • 16.3.3 Becton Dickinson and Company
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
    • 16.3.3.3 Financials
    • 16.3.3.4 SWOT Analysis
  • 16.3.4 Boston Scientific Corporation
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
    • 16.3.4.3 Financials
    • 16.3.4.4 SWOT Analysis
  • 16.3.5 Caldera Medical Inc.
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
  • 16.3.6 Coloplast A/S
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
    • 16.3.6.3 Financials
    • 16.3.6.4 SWOT Analysis
  • 16.3.7 ConvaTec Group plc
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
    • 16.3.7.3 Financials
  • 16.3.8 Cook Group Inc.
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 Johnson & Johnson
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
    • 16.3.9.3 Financials
    • 16.3.9.4 SWOT Analysis
  • 16.3.10 Kimberly-Clark Corporation
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
    • 16.3.10.4 SWOT Analysis
  • 16.3.11 Laborie Medical Technologies Inc.
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
  • 16.3.12 Medtronic plc
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio
    • 16.3.12.3 Financials
    • 16.3.12.4 SWOT Analysis
  • 16.3.13 Teleflex Incorporated
    • 16.3.13.1 Company Overview
    • 16.3.13.2 Product Portfolio
    • 16.3.13.3 Financials
    • 16.3.13.4 SWOT Analysis